Clinical Trial

Efficacy and Safety for Telitacicept in the Remission Maintenance Treatment of ANCA-associated Vasculitis (TTCAZAREM)

Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated July 28, 2023 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study is a prospective, open-labelled, randomized, controlled, single-center clinical trial. The aim of this study is to compare the remission rate of patients treated with Telitacicept combined with azathioprine and azathioprine alone in remission-maintenance treatment of AAV.
Trial Details
NCT Number NCT05965284
Lead Sponsor Chinese SLE Treatment And Research Group
Conditions ANCA-associated Vasculitis, Maintenance Therapy
Enrollment 40 participants
Start Date 2023-03-09
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2023-07-28